TB-500 makes more sense when: The injury is deep or hard to reach with an injection (spine, deep hip, cardiac tissue) You're dealing with multiple injuries at the same time Recovery involves systemic inflammation rather than something localized BPC-157 makes more sense when: The injury is easy to inject near (knee, shoulder, elbow, ankle) Gut healing is the main goal, since BPC-157's strongest documented effects are in the GI tract You're targeting a neurological issue through a localized administration route Neither peptide has human RCT data for musculoskeletal use yet
For example, HSP90AA1 protein is increased in BRCA tissues compared with normal tissues, and is associated with poor overall survival (OS) 16
Read more about high-volume injections as treatment for Achilles tendinopathy
Delgado M, Ganea D (2013) Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions
We explore the science underlying this amazing peptide, looking at its modes of action and the different ways it can speed up recovery, from joint injuries to muscle strains
Two peptides we often discuss with patients in this category target different but related pathways
